Analyst Whit Mayo from Leerink Partners maintained a Hold rating on Pediatrix Medical Group and keeping the price target at $14.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Whit Mayo’s rating is based on a combination of factors, including the recent trends in birth rates and payer mix in key markets for Pediatrix Medical Group. The data from the May Birth Tracker indicates a year-over-year increase in births, which is a positive sign. However, Mayo remains cautious about the sustainability of these trends, particularly as the company laps the favorable conditions from the previous year.
Additionally, while the Florida market shows strong commercial birth rates, there is concern that the benefits from these trends may not be long-lasting. The commercial birth mix in Florida has reached record highs, but the analyst notes that these tailwinds could diminish as the effects of previous redeterminations wane. Overall, Mayo’s Hold rating reflects a balanced view of the potential risks and opportunities facing Pediatrix Medical Group.